The Pharmacy Quality Assurance Commission adopted emergency rules to reduce burdens on practitioners prescribing Schedule II substances during the COVID-19 outbreak. The emergency rule amends WAC 246-887-020 and increases the duration of time a practitioner has to deliver a signed prescription when authorizing an emergency prescription of a Schedule II substance to the pharmacy from seven days to fifteen days. The emergency redefines what is a “signed prescription".
Emergency rules filed on April 21, 2020, under WSR 20-09-133 are effective immediately and will remain enforce for 120 days.
See the Pharmacy Commission’s Plan-19 for information on Commission guidance, frequently asked questions, and more regarding COVID-19.